|
|
|
Insider
Information: |
Urdal David |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
669,750 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
669,750 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
644,750 |
2003-09-03 |
0 |
Premium* |
|
Ore Pharmaceuticals Inc |
ORXE |
Director |
2007-11-27 |
25,000 |
2007-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2006-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
494,918 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2007-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
506,283 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2007-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
540,033 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
32,566 |
572,599 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2009-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
662,599 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2010-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
684,260 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2010-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
676,613 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
14,026 |
688,495 |
0 |
- |
|
DNDN |
Dendreon Corp |
Director |
|
2012-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
594,750 |
0 |
- |
|
DNDN |
Dendreon Corp |
Director |
|
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
619,750 |
0 |
- |
|
DNDN |
Dendreon Corp |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
644,750 |
0 |
- |
|
DNDN |
Dendreon Corp |
Chief Scientific Officer |
|
2004-07-20 |
4 |
OE |
$0.68 |
$63,312 |
D/D |
44,486 |
454,303 |
|
- |
|
ORXE |
Ore Pharmaceuticals Inc |
Director |
|
2007-11-27 |
4 |
B |
$0.90 |
$22,500 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Science Officer |
|
2007-06-29 |
5 |
A |
$3.43 |
$17,128 |
D/D |
5,000 |
545,033 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2006-12-29 |
5 |
A |
$3.54 |
$408 |
D/D |
115 |
495,033 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2009-12-31 |
5 |
A |
$3.93 |
$21,249 |
D/D |
5,411 |
668,010 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2010-12-31 |
5 |
A |
$3.93 |
$21,249 |
D/D |
5,411 |
676,613 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2006-06-08 |
4 |
B |
$4.04 |
$20,200 |
D/D |
5,000 |
481,426 |
2.81 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2006-06-30 |
5 |
A |
$4.11 |
$19,229 |
D/D |
4,674 |
494,918 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2010-05-21 |
4 |
OE |
$4.41 |
$735,071 |
D/D |
118,049 |
762,309 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2011-08-09 |
4 |
OE |
$4.41 |
$57,364 |
D/D |
12,035 |
588,115 |
0 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2009-05-04 |
4 |
OE |
$4.90 |
$2,545,228 |
D/D |
325,467 |
708,217 |
0 |
- |
|
DNDN |
Dendreon Corp |
officerTitle |
|
2006-01-19 |
4 |
A |
$5.50 |
$82,500 |
D/D |
15,000 |
476,426 |
|
- |
|
DNDN |
Dendreon Corp |
Chief Scientific Officer |
|
2005-03-17 |
4 |
B |
$5.58 |
$24,565 |
D/D |
4,400 |
461,426 |
2.74 |
- |
|
DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
|
2005-01-31 |
5 |
S |
$5.78 |
$15,739 |
D/D |
(2,723) |
457,026 |
0 |
- |
|
50 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|